Alok Dalal
Stock Analyst at Jefferies
(3.15)
# 2,491
Out of 4,581 analysts
83
Total ratings
63.8%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Alok Dalal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: CIPLA Cipla Limited | Maintained: Sell | ₹1,170 | ₹1,479 | -20.88% | 8 | Jul 28, 2026 | |
| NSE: LAURUSLABS Laurus Labs Limited | Maintained: Hold | ₹1,100 → ₹1,700 | ₹1,777 | -4.33% | 4 | Jul 28, 2026 | |
| NSE: EMCURE Emcure Pharmaceuticals Limited | Maintained: Buy | ₹1,970 → ₹2,100 | ₹1,912 | +9.85% | 8 | Jun 24, 2026 | |
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,000 → ₹6,500 | ₹5,841 | +11.28% | 5 | May 29, 2026 | |
| NSE: ENTERO Entero Healthcare Solutions Limited | Maintained: Buy | ₹1,350 → ₹1,500 | ₹1,215 | +23.49% | 6 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹9,120 → ₹9,700 | ₹8,970 | +8.14% | 4 | May 25, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹3,100 → ₹3,000 | ₹2,602 | +15.30% | 6 | May 20, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Hold | ₹1,970 → ₹2,080 | ₹2,534 | -17.92% | 4 | May 18, 2026 | |
| NSE: MEDANTA Global Health Limited | Maintained: Buy | ₹1,440 → ₹1,500 | ₹1,408 | +6.54% | 5 | May 18, 2026 | |
| NSE: SAILIFE Sai Life Sciences Limited | Maintained: Buy | ₹1,300 → ₹1,270 | ₹1,305 | -2.66% | 4 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | ₹300.00 | ₹426.60 | -29.68% | 1 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,380 → ₹1,500 | ₹1,113 | +34.81% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,400 → ₹2,250 | ₹2,429 | -7.38% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,210 → ₹1,100 | ₹1,145 | n/a | 2 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,620 → ₹1,700 | ₹1,335 | n/a | 3 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,350 → ₹1,150 | ₹1,122 | n/a | 3 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹6,280 → ₹6,200 | ₹7,858 | n/a | 2 | May 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹260.00 | ₹194.59 | n/a | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,850 → ₹3,140 | ₹3,406 | n/a | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹890.00 → ₹650.00 | ₹386.25 | n/a | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹860.00 → ₹850.00 | ₹947.35 | n/a | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,260 → ₹2,265 | ₹2,007 | n/a | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | ₹400.00 | ₹426.50 | n/a | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $68 → $12 | $11.76 | n/a | 4 | Jan 30, 2024 |
Cipla Limited
Jul 28, 2026
Maintained: Sell
Price Target: ₹1,170
Current: ₹1,479
Upside: -20.88%
Laurus Labs Limited
Jul 28, 2026
Maintained: Hold
Price Target: ₹1,100 → ₹1,700
Current: ₹1,777
Upside: -4.33%
Emcure Pharmaceuticals Limited
Jun 24, 2026
Maintained: Buy
Price Target: ₹1,970 → ₹2,100
Current: ₹1,912
Upside: +9.85%
Alkem Laboratories Limited
May 29, 2026
Maintained: Buy
Price Target: ₹6,000 → ₹6,500
Current: ₹5,841
Upside: +11.28%
Entero Healthcare Solutions Limited
May 28, 2026
Maintained: Buy
Price Target: ₹1,350 → ₹1,500
Current: ₹1,215
Upside: +23.49%
Apollo Hospitals Enterprise Limited
May 25, 2026
Maintained: Buy
Price Target: ₹9,120 → ₹9,700
Current: ₹8,970
Upside: +8.14%
Mankind Pharma Limited
May 20, 2026
Maintained: Buy
Price Target: ₹3,100 → ₹3,000
Current: ₹2,602
Upside: +15.30%
Gland Pharma Limited
May 18, 2026
Maintained: Hold
Price Target: ₹1,970 → ₹2,080
Current: ₹2,534
Upside: -17.92%
Global Health Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,440 → ₹1,500
Current: ₹1,408
Upside: +6.54%
Sai Life Sciences Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,300 → ₹1,270
Current: ₹1,305
Upside: -2.66%
May 13, 2026
Downgraded: Sell
Price Target: ₹300.00
Current: ₹426.60
Upside: -29.68%
Aug 14, 2025
Maintained: Buy
Price Target: ₹1,380 → ₹1,500
Current: ₹1,113
Upside: +34.81%
Aug 7, 2025
Upgraded: Buy
Price Target: ₹2,400 → ₹2,250
Current: ₹2,429
Upside: -7.38%
Jul 24, 2025
Maintained: Sell
Price Target: ₹1,210 → ₹1,100
Current: ₹1,145
Upside: n/a
May 31, 2025
Maintained: Hold
Price Target: ₹1,620 → ₹1,700
Current: ₹1,335
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ₹1,350 → ₹1,150
Current: ₹1,122
Upside: n/a
May 18, 2025
Maintained: Hold
Price Target: ₹6,280 → ₹6,200
Current: ₹7,858
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: ₹260.00
Current: ₹194.59
Upside: n/a
Apr 30, 2025
Maintained: Buy
Price Target: ₹2,850 → ₹3,140
Current: ₹3,406
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: ₹890.00 → ₹650.00
Current: ₹386.25
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: ₹860.00 → ₹850.00
Current: ₹947.35
Upside: n/a
Jan 31, 2025
Maintained: Buy
Price Target: ₹2,260 → ₹2,265
Current: ₹2,007
Upside: n/a
Jan 6, 2025
Upgraded: Hold
Price Target: ₹400.00
Current: ₹426.50
Upside: n/a
Jan 30, 2024
Downgraded: Sell
Price Target: $68 → $12
Current: $11.76
Upside: n/a